Recently, allicin was reported to induce apoptosis and reduce Nrf2, HO-1, and p-Akt levels in doxorubicin-resistant MCF-7 and MDA-MB-231 cells, supporting the potential of this garlic compound in improving the effects of this chemotherapeutic in breast cancer [55]. Here, AKT1 is linked to breast carcinoma.